We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CNAC market cap is 105.81M. The company's latest EPS is USD -2.9462 and P/E is -1.05.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.48M | 3.98M | 3.92M | 3.92M | 3.85M |
| Operating Income | -32.05M | -32.13M | -19.81M | -21.85M | -20.51M |
| Net Income | -31.27M | -31.36M | -19.16M | -19.09M | -20.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.36M | 5.89M | 11.84M | 14.52M | 15.3M |
| Operating Income | -17.61M | -35.29M | -77.4M | -118.17M | -103.74M |
| Net Income | -19.69M | -35.25M | -78.34M | -116.68M | -100.89M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 177.12M | 157.07M | 137.9M | 121.93M | 102.97M |
| Total Liabilities | 69.88M | 69M | 64.83M | 64.76M | 62.98M |
| Total Equity | 107.24M | 88.08M | 73.06M | 57.18M | 39.99M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.21M | 69.78M | 248.31M | 202.08M | 121.93M |
| Total Liabilities | 5.72M | 6.29M | 18.61M | 69.72M | 64.76M |
| Total Equity | 12.49M | 63.49M | 229.7M | 132.35M | 57.18M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.03M | -45.23M | -64.27M | -76.98M | -17.12M |
| Investing | -8.19M | 4.86M | 17.62M | 29.86M | 7.83M |
| Financing | 916k | 5.38M | 6.1M | 6.08M | 122k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.79M | -28.68M | -62.11M | -95.26M | -76.98M |
| Investing | -210k | -41.34M | -12.51M | -4.32M | 29.86M |
| Financing | 28.62M | 78.9M | 230.28M | 917k | 6.08M |
| Market Cap | 105.81M |
| Price to Earnings Ratio | -1.05 |
| Price to Sales Ratio | 6.92 |
| Price to Cash Ratio | 2.88 |
| Price to Book Ratio | 1.85 |
| Dividend Yield | - |
| Shares Outstanding | 34.24M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.5 (55.56%) |
| Company Name | Constellation Alpha Capital Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://dermtech.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
